Replies to post #2801 on Mind Medicine (MindMed) Inc (MNMD)

[kayoboi]

.@mindmedco CEO JR Rahn on the launch of the first psychedelic ETF: “What we’re seeing now is... a demand from both retail investors and institutional investors on how to best index this space and how to gain the most exposure to the most amount of clinical trials.” pic.twitter.com/8I2HX91COl

— Yahoo Finance (@YahooFinance) January 25, 2021